Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

"And Though It Is Little, It Is Mighty…" CBD Products Inc Launches 'Cannabinoid Balance' With Nanozorb™ Technology

The team behind Cannabinoid Balance focus on their products supporting the symptoms of conditions, as opposed to the underlying conditions themselves. This is their way of showing the transparency and integrity they believe the industry needs to display, in order to reassure the consumer.


News provided by

CBD Products, Inc.

Sep 22, 2020, 06:00 ET

Share this article

Share toX

Share this article

Share toX


LA JOLLA, Calif., Sept. 22, 2020 /PRNewswire-PRWeb/ -- CBD Products Inc. is a multi-channel cannabidiol life company, established in 2018 to collate and publish cannabinoid news, research and clinical trials from around the world, to an increasingly engaged audience.

In the two years since it launched, CBD Products Inc. has published hundreds of articles and gained insights on more than 25,000 cannabinoid consumers. In doing so, the California based company came to realize that the industry was facing a crisis of consumer trust associated with lower barriers to entry and a perceived reduction in quality.

We believe in supporting the relief of symptoms. That’s why our specially formulated products combines cannabinoids and active natural ingredients that are linked to relieving pain, aiding sleep, reducing inflammation, easing anxiety and lowering blood pressure.

Post this

Because of this, CBD Products Inc. sought out the top U.S cannabinoid producers and manufacturers with the sole intention of crafting a product that restores U.S consumer confidence in the compounds that CBD Products Inc. believe will fuel the 'healthcare movement of a generation'.

According to CBD Products Inc. founder Anthony Tribunella, who has been in the industry for more than ten years; "Over the past eighteen months, I have watched the quality in the cannabinoid industry deteriorate. Via CBD World News, CBD Pet and CBD Products.com, I have witnessed first hand, the conjecture of consumers who are desperately seeking a product they feel they can trust. My intention was never to start a consumer brand, but having heard the feedback on what's available, I felt duty bound to deliver a product line that goes back to basics, i.e. 'honest cannabinoids, simply balanced."

Cannabinoid Balance for symptoms, rather than conditions…
Because the science of cannabinoids is still in its relative infancy, the team behind Cannabinoid Balance focus on their products supporting the symptoms of conditions, as opposed to the underlying conditions themselves. This is their way of showing the transparency and integrity they believe the industry needs to display, in order to reassure the consumer. As Anthony affirms; "we believe in supporting the relief of symptoms, rather than claiming to be a miracle cure. That's why each of our specially formulated Cannabinoid Balance products combines cannabinoids and active natural ingredients that are linked to relieving pain, aiding sleep, reducing inflammation, easing anxiety and lowering blood pressure."

Experience, science and effectiveness...
Like all great products, Cannabinoid Balance is inspired by personal experience, but delivered with a primal passion to give the consumer the most impactful CBD experience possible. For Cannabinoid Balance, this is only achieved when their cannabinoids are delivered effectively and efficiently, and for them, this all starts with the inclusion of proprietary NanoZorb™ Technology.

Nano Technology supports fast absorption of cannabinoids and terpenes into the bloodstream. By using NanoZorb™ in our products, we can make CBD intake more efficient and by bypassing the digestive tract, we can counter the CBD degradation that occurs during digestion. Cannabinoid Balance is made with NanoZorb™ technology in an FDA registered facility, so you can rest assured that it is safe and effective. It is all-natural and free of synthetics, sugar, binders, fillers, wax, shellac, talcum, and animal gelatin. It contains no yeast, wheat, corn, soy, gluten, salt, dairy, artificial flavors, sweeteners, colors, or preservatives.

Using NanoZorb™ Technology makes Cannabinoid Balance fast-acting, more stable, and ensures that our products offer increased bioavailability as well as increased cellular penetration, activity & function.

It sounds like something out of a Science Fiction movie, but this incredible real-life science is safe, simple, and effective. Nanotechnology describes the creation of minute particles, so small in fact, that millions of them could fit on to just one pinhead. These tiny particles are small enough to be absorbed directly into the bloodstream and delivered to every cell. This means that unlike traditional delivery methods, the constituents being delivered, in our case CBD and terpenes, get to work as quickly as possible. This makes the product more efficient and therefore more cost-effective per mg. In fact, because of the NanoZorb™ technology in Cannabinoid Balance, your body only needs 10% of the normal dosage to experience the same effect.

Cannabinoid Balance Products are:

  • Crafted from registered organic USA hemp
  • Non-THC / Non-GMO and CO2 Extracted
  • Free from Winterization, Decarboxylation, and pesticides
  • Formulated using proprietary NanoZorb™ Technology

And the launch line-up Includes:

  • Cannabinoid Balance Original+ (1,000mg and 3,000mg)
  • Cannabinoid Balance Sleep+ (1,000mg)
  • Cannabinoid Balance CBD Gummies+ (750mg)
  • Cannabinoid Balance Pain Relief Cream+ (1000mg)
  • Cannabinoid Balance Pet+ (250mg)

Cannabinoid Balance is brought to consumers by a team of scientists and researchers who constantly strive to deliver a 'better' CBD experience in their FDA registered laboratory. They are pharmaceutical grade and adhere to the strictest guidelines. They therefore contain no binders, fillers, excipients, dyes, or unknown substances, are 100% THC free, and produced with organic cannabinoids derived only from U.S. registered hemp.

---

NOTES TO THE EDITOR

---

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb™ Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email [email protected].

SOURCE CBD Products, Inc.

Related Links

http://www.cbdproducts.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.